Kura Oncology KURA
NASDAQ KURA
$9.79 -0.09 (-0.91%)
As of: Oct 22, 2026 · 10:26 AM EDT

Kura Oncology (KURA) Receivables (2024 - 2026)

Updated

Kura Oncology (KURA) posted Receivables of $9.45 million for Q2 2026, up 106.5% from $4.57 million a year earlier and up 1.0% from the prior quarter.

Analysis

Kura Oncology (KURA) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, Kura Oncology's Receivables came in at $8.8 million, up 327.4% from FY2024.

  • In prior years, Kura Oncology's Receivables was $2.06 million in FY2024.
  • Quarterly Receivables has run from a low of $2.06 million in Q4 2024 to a high of $48.75 million in Q1 2025 over five years.
  • According to Business Quant data, Receivables for the three prior quarters was $9.35 million (Q1 2026), $8.8 million (Q4 2025) and $35.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn 19.05 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn 13.82 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 12.49 Bn
10 Kura Oncology 870.78 Mn -1.45 Bn 20.63 Mn 9.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.45 Mn
Mar 31, 2026 9.35 Mn
Dec 31, 2025 8.80 Mn
Sep 30, 2025 35.94 Mn
Jun 30, 2025 4.57 Mn
Mar 31, 2025 48.75 Mn
Dec 31, 2024 2.06 Mn
API Access

Kura Oncology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=KURA&period=max&api_key=YOUR_API_KEY